Advances in Biomaterial Scaffolds for Spinal Cord Tissue Engineering
SCI is a devastating condition characterized by the loss of motor, sensory, and autonomic function, with limited treatment options. This paper reviews the physiological architecture of the healthy spinal cord, the pathological mechanisms underlying spinal cord injury, and the current clinical landscape of mechanical and regenerative therapies. Market analysis reveals a growing demand for implantable, programmable, and biologically active solutions as populations age and long-term care costs continue to rise. Recent advances in scaffold design, stem cell therapies, neuromodulation, and hybrid technologies are driving innovation in both academic research and commercial development. Together, these trends point toward a future of personalized, multimodal regenerative medicine for spinal cord repair.